Hologic (HOLX) Reports In-Line Q4 EPS; Guides Q1 Modestly Below Views
Get Alerts HOLX Hot Sheet
Price: $77.96 +0.79%
EPS Growth %: -7.5%
Financial Fact:
Cost of product sales: 195.5M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: -7.5%
Financial Fact:
Cost of product sales: 195.5M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $813.5 million versus the consensus estimate of $806.55 million.
GUIDANCE:
Hologic sees Q1 2019 EPS of $0.55-$0.57, versus the consensus of $0.58. Hologic sees Q1 2019 revenue of $800-815 million, versus the consensus of $817.51 million.
Hologic sees FY2019 EPS of $2.38-$2.42, versus the consensus of $2.42. Hologic sees FY2019 revenue of $3.29-3.335 billion, versus the consensus of $3.31 billion.
For earnings history and earnings-related data on Hologic (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
- Forian Inc. (FORA) Tops Q4 EPS by 3c, provides outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!